In May 2011, Pfizer executives set aside $772 million for lawsuits regarding the menopause medication Prempro, a drug manufactured by Wyeth and Pfizer. Prempro has been linked to causing breast cancer in women after long-term use. Since as early as 2002, nearly 4,000 women who have contracted breast cancer after taking Prempro have filed suit against Pfizer for failure to warn of side effects and aggressive promotion of Prempro. Pfizer failed to adequately test and research Prempro to determine its adverse side effects from long-term use, resulting in a large number of women contracting breast cancer.

The drug manufacturer has recently agreed to pay $330 million to resolve 2,200 cases in which women risked higher rates of developing breast cancer.   Prempro was approved as a hormone therapy drug by the FDA in 1995. It combines progestin and estrogen to treat the many symptoms of menopause and is used by 15-20% of post-menopausal women in the United States. Its link to breast cancer has become an increasing problem and numerous lawsuits have been filed against this pharmaceutical giant.  

Women all over the country who experienced these complications are seeking compensation for medical bills, damages, suffering, and other related issues. If you or someone you know has suffered from breast cancer as a result of taking Prempro, contact a Prempro drug litigation attorney to discuss your legal options.